The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Coiante Scott M since 2018.
The trader's CIK number is 1608536.
At the time of the last reporting, Coiante Scott M was the Chief Financial Officer of Aprea Therapeutics, Inc.. (stock ticker symbol APRE).
Also see all insider trading activities at Aprea Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | AGRX | 0 | $0 | 0 | $0 | 33,570 | $0 |
2018 | AGRX | 0 | $0 | 0 | $0 | 17,500 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | APRE | 2,500 | $37,500 | 0 | $0 | 0 | $0 |
1. Agile Therapeutics Inc (AGRX)
2. Aprea Therapeutics, Inc. (APRE)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-01-25 | AGRX | Option Ex | 17,500 | .00 | 0 |
2019-01-24 | AGRX | Option Ex | 16,070 | .00 | 0 |
2018-01-25 | AGRX | Option Ex | 17,500 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-10-07 | APRE | Buy | 2,500 | 15.00 | 37,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coiante Scott M (Chief Financial Officer of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.